PharmaDiversityJobBoard-Diversity Job Board connecting diversity & minority job seekers with Pharmaceutical jobs. GE Healthcare Jobs (GE)
  Home  |  Login  |  Job Seeker Register  |  Employer Register    You're not logged in!
Translate:

Watson Pharmaceuticals Jobs

 
Click links to read Current News for this Featured Employer    Watson and Itero Enter Worldwide License Agreement on Biologic Development Candidate | Watson to Host Conference Call and Webcast to Discuss Second Quarter 2010 Earnings | FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception | Watson Q1 Net Revenue Climbs 28 Percent to $857 Million | Watson Confirms EVISTA(R) Patent Challenge | Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 7th | Watson to Host Conference Call and Webcast to Discuss First Quarter 2010 Earnings | Watson to Present at Barclay's 2010 Global Healthcare Conference | Watson to Present at CLSA/Asia USA Investor's Forum | Watson Reports Net Revenue of $786 Million for the Fourth Quarter 2009 | Watson Files FDA Application for Generic Aplenzin(TM) ER | Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook | Watson Announces Preliminary Financial Performance for FY 2009 | Watson Files FDA Application for Generic LoSeasonique(R) | Watson to Present at 28th Annual JPMorgan Healthcare Conference | Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy | Watson to Present at Credit Suisse Healthcare Conference | Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66 | Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand | Watson Prices $850 Million of Senior Unsecured Notes | Watson Announces Offering of Senior Unsecured Notes | Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook | Watson CFO Mark W. Durand to Take Leave of Absence | Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast | Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) | Watson Provides Update on Ferrlecit(R) Supply and Distribution Agreement | Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH) | Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid | /C O R R E C T I O N -- Watson Pharmaceuticals, Inc./ | Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook | Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement | Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder | Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules | Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer | Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH) | Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder at SUNA's Annual Conference | /C O R R E C T I O N -- Watson Pharmaceuticals, Inc./ | Watson Pharmaceuticals Reports Second Quarter 2008 Results |
 
  
Items 1-25/56 displayed. [1-25][26-50][51-56] next
SaveDateJob TitleCity CountryStateCompany NamePay
Jul 29 Mgr, Regulatory Affairs Proprietary Operations
 Salt Lake City, USA Utah  Watson Pharmaceuticals Not specified
Jul 29 Professional Sales Representative
 Washington, USA Washington DC  Watson Pharmaceuticals Not specified
Jul 28 Medical Liaison II
 Philadelphia, USA Pennsylvania  Watson Pharmaceuticals Not specified
Jul 28 Mgr, Regulatory Affairs
 Morristown, USA New Jersey  Watson Pharmaceuticals Not specified
Jul 24 HR Coordinator
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 19 Regulatory Affairs Assoc II
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 19 Inside Sales Representative I
 Corona, USA California  Watson Pharmaceuticals Not specified
Jul 16 Credit Analyst
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 14 Government Affairs Coordinator
 Washington, USA Washington DC  Watson Pharmaceuticals Not specified
Jul 10 Professional Sales Representative
 Joliet, USA Illinois  Watson Pharmaceuticals Not specified
Jul 10 Professional Sales Representative
 Ann Arbor, USA Michigan  Watson Pharmaceuticals Not specified
Jul 10 Professional Sales Representative
 Riverside, USA California  Watson Pharmaceuticals Not specified
Jul 08 General Maintenance Mechanic IV (HVAC-1st Shift)
 Corona, USA California  Watson Pharmaceuticals Not specified
Jul 08 Research Fellow
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 08 Quality Auditor Sr.
 Salt Lake City, USA Utah  Watson Pharmaceuticals Not specified
Jul 08 Mgr, Biopharmaceutics
 Morristown, USA New Jersey  Watson Pharmaceuticals Not specified
Jul 06 Inside Sales Representative I (Physicians)
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 03 Chemist III
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 03 Quality Assurance Engineer Principal
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 03 Lab Systems Administrator Sr.
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 03 Chemist I
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 03 Administrative Assistant II
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jul 03 Chemist II
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jun 29 Scientist Principal
 Ft. Lauderdale, USA Florida  Watson Pharmaceuticals Not specified
Jun 26 Supv, Quality Assurance
 Salt Lake City, USA Utah  Watson Pharmaceuticals Not specified